Skip to main content
Journal cover image

Renal function, atherothrombosis extent, and outcomes in high-risk patients.

Publication ,  Journal Article
Dumaine, RL; Montalescot, G; Steg, PG; Ohman, EM; Eagle, K; Bhatt, DL; REACH Registry Investigators,
Published in: Am Heart J
July 2009

BACKGROUND: Although prior data showed an association between chronic kidney disease (CKD) and atherothrombotic events, little is known about the risk profile and specific outcomes of atherothrombotic outpatients with CKD. METHODS: More than 69,000 outpatients at risk of atherothrombotic events were enrolled in the REACH Registry. Creatinine clearance (CrCl) was available for 51,208 patients divided into 4 groups: normal (CrCl > or =90 mL/min, n = 13,949), mild (60-89 mL/min, n = 19,474), moderate (30-59 mL/min, n = 15,883), and severe CKD (CrCl <30 mL/min, n = 1902). Baseline characteristics, number of arterial beds overtly affected, medications, overall mortality, cardiovascular death, myocardial infarction, stroke, congestive heart failure, peripheral arterial events, and bleeding events were assessed according to renal function. RESULTS: The number of arterial beds affected increased with severity of CKD. However, patients with severe CKD were less likely to receive medications of proven benefit. Severe CKD was an independent correlate of all-cause mortality, cardiovascular mortality, myocardial infarction, congestive heart failure, peripheral arterial revascularization, or amputation. CONCLUSION: One third of outpatients at risk for atherothrombotic events have moderate to severe CKD. They are less likely to receive beneficial therapies despite a higher atherothrombotic burden and worse outcomes.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

July 2009

Volume

158

Issue

1

Start / End Page

141 / 148.e1

Location

United States

Related Subject Headings

  • Stroke
  • Statistics as Topic
  • Risk Factors
  • Prospective Studies
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Kidney Failure, Chronic
  • Humans
  • Hemorrhage
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dumaine, R. L., Montalescot, G., Steg, P. G., Ohman, E. M., Eagle, K., Bhatt, D. L., & REACH Registry Investigators, . (2009). Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J, 158(1), 141-148.e1. https://doi.org/10.1016/j.ahj.2009.05.011
Dumaine, Raphaelle L., Gilles Montalescot, Ph Gabriel Steg, E Magnus Ohman, Kim Eagle, Deepak L. Bhatt, and Deepak L. REACH Registry Investigators. “Renal function, atherothrombosis extent, and outcomes in high-risk patients.Am Heart J 158, no. 1 (July 2009): 141-148.e1. https://doi.org/10.1016/j.ahj.2009.05.011.
Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL, et al. Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J. 2009 Jul;158(1):141-148.e1.
Dumaine, Raphaelle L., et al. “Renal function, atherothrombosis extent, and outcomes in high-risk patients.Am Heart J, vol. 158, no. 1, July 2009, pp. 141-148.e1. Pubmed, doi:10.1016/j.ahj.2009.05.011.
Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL, REACH Registry Investigators. Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J. 2009 Jul;158(1):141-148.e1.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

July 2009

Volume

158

Issue

1

Start / End Page

141 / 148.e1

Location

United States

Related Subject Headings

  • Stroke
  • Statistics as Topic
  • Risk Factors
  • Prospective Studies
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Kidney Failure, Chronic
  • Humans
  • Hemorrhage